Other
COVID-19 infection
COVID-19 infection is an intervention with 5 clinical trials. Historical success rate of 75.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
75.0%
Trials by Status
completed360%
terminated120%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completed
SARS-COV-2 VARIANTS' EFFECT ON PREGNANCY AND LONG-TERM OUTCOMES AMONG PREGNANT WOMEN AND THEIR NEWBORNS IN ESTONIA
NCT06806696
unknown
Anesthesia Technique in COVID-19 Positive Hip Fracture Patients
NCT05133648
completed
Socio-economic, Meteorological and Environmental Factors Associated With the Incidence of COVID-19
NCT05379621
completed
COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave
NCT04782427
terminated
COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases
NCT04335747
Clinical Trials (5)
Showing 5 of 5 trials
NCT06806696
SARS-COV-2 VARIANTS' EFFECT ON PREGNANCY AND LONG-TERM OUTCOMES AMONG PREGNANT WOMEN AND THEIR NEWBORNS IN ESTONIA
NCT05133648
Anesthesia Technique in COVID-19 Positive Hip Fracture Patients
NCT05379621
Socio-economic, Meteorological and Environmental Factors Associated With the Incidence of COVID-19
NCT04782427
COVID-19 Infections and Mortality in Long-term Care Facilities During the First Wave
NCT04335747
COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5